Sara Koblitz is speaking at Food and Drug Law Journal’s 2023 Symposium: Regulating on Shifting Sands: Analyzing the Impact of Recent and Upcoming Federal Court Decisions on FDA’s Authority
Moderator: Orphan Drug Exclusivity: From Depomed to Jazz, a Review of Key Case Law and Themes in FDA’s Interpretation of ODD and ODERelated Professionals
- Sara W. Koblitz
Director